Foghorn Therapeutics Inc.

Healthcare · Biotechnology · United States

Last price 2.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 124.12M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leuk...